Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production

American Journal of Physiology - Cell Physiology

Volumn 284, Issue 2 53-2, 2003, Pages

  Sayen, M R ^a   Gustafsson, Åsa B ^a   Sussman, Mark A ^b   Molkentin, Jeffery D ^b   Gottlieb, Roberta A ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Bioenergetics; Genetic models of heart failure; Hypertrophy; Mitochondria

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ASCORBIC ACID; CALCINEURIN; COMPLEMENTARY DNA; CYTOCHROME C OXIDASE; MITOCHONDRIAL PROTEIN; OXYGEN; PRISTANE; SUCCINIC ACID; SUPEROXIDE; TROPOMODULIN;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON TRANSPORT; GENE OVEREXPRESSION; HEART FAILURE; HEART FUNCTION; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART SIZE; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; OXYGEN ELECTRODE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; RESPIRATION CONTROL; SARCOLEMMA; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALIA; FORMICIDAE; MUS MUSCULUS; TRIXIS;

EID: 0037303514     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00336.2002     Document Type: Article

References (46)

1. q signaling: a common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA 95: 10140-10145, 1998.
2. Bai Y and Attardi G. The mtDNA-encoded ND6 subunit of mitochondrial NADH dehydrogenase is essential for the assembly of the membrane arm and the respiratory function of the enzyme. EMBO J 17: 4848-4858, 1998.
3. Becker LB, van den Hoek TL, Shao ZH, Li CQ, and Schumacker PT. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol Heart Circ Physiol 277: H2240-H2246, 1999.
4. 2+-dependent gene expression mediated by MEF2 transcription factors. J Biol Chem 275: 197-209, 2000.
5. Cesselli D, Jakoniuk I, Barlucchi L, Beltrami AP, Hintze TH, Nadal-Ginard B, Kajstura J, Leri A, and Anversa P. Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 89: 279-286, 2001.
6. Chance B and Higihara B. Direct spectroscopic measure measurements of interaction of components of the respiratory chain with ATP, ADP, phosphate, and uncoupling agents. In: Proceedings on Intracellular Respiration. Moscow: Congress Biochemistry, 1961, p. 3-26.
7. De Windt LJ, Lim HW, Bueno OF, Liang Q, Delling U, Braz JC, Glascock BJ, Kimball TF, del Monte F, Hajjar RJ, and Molkentin JD. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc Natl Acad Sci USA 98: 3322-3327, 2001.
8. 2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways. J Biol Chem 275: 13571-13579, 2000.
9. De Windt LJ, Lim HW, Taigen T, Wencker D, Condorelli G, Dorn GW, Kitsis RN, and Molkentin JD. Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: an apoptosis-independent model of dilated heart failure. Circ Res 86: 255-263, 2000.
10. Delling U, Tureckova J, Lim HW, De Windt LJ, Rotwein P, and Molkentin JD. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Mol Cell Biol 20: 6600-6611, 2000.
11. Esposito LA, Melov S, Panov A, Cottrell BA, and Wallace DC. Mitochondrial disease in mouse results in increased oxidative stress. Proc Natl Acad Sci USA 96: 4820-4825, 1999.
12. Fleming I, Michaelis UR, Bredenkotter D, Fisslthaler B, Dehghani F, Brandes RP, and Busse R. Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res 88: 44-51, 2001.
13. Gergel D, Misik V, Riesz P, and Cederbaum AI. Inhibition of rat and human cytochrome P4502E1 catalytic activity and reactive oxygen radical formation by nitric oxide. Arch Biochem Biophys 337: 239-250, 1997.
14. He H, Chen M, Scheffler NK, Gibson BW, Spremulli LL, and Gottlieb RA. Phosphorylation of mitochondrial elongation factor Tu in ischemic myocardium: basis for chloramphenicol-mediated cardioprotection. Circ Res 89: 461-467, 2001.
15. Ide T, Tsutsui H, Kinugawa S, Utsumi H, Kang D, Hattori N, Uchida K, Arimura K, Egashira K, and Takeshita A. Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 85: 357-363, 1999.
16. Karwatowska-Prokopczuk E, Nordberg J, Li HL, Engler RL, and Gottlieb RA. Effect of the vacuolar proton ATPase on intracellular pH, calcium, and on apoptosis in neonatal cardiomyocytes during metabolic inhibition and recovery. Circ Res 82: 1139-1144, 1998.
17. Kuo TH and Giacomelli FWJ. Oxidative metabolism of Polytron vs. Nagarse mitochondria in hearts of genetically diabetic mice. Biochim Biophys Acta 806: 9-15, 1985.
18. Lenka N, Vijayasarathy C, Mullick J, and Avadhani NG. Structural organization and transcription regulation of nuclear genes encoding the mammalian cytochrome c oxidase complex. Prog Nucleic Acid Res Mol Biol 61: 309-344, 1998.
19. Lesnefsky EJ, Tandler B, Ye J, Slabe TJ, Turkaly J, and Hoppel CL. Myocardial ischemia decreases oxidative phosphorylation through cytochrome oxidase in subsarcolemmal mitochondria. Am J Physiol Heart Circ Physiol 273: H1544-H1554, 1997.
20. Liang Q, De Windt LJ, Witt SA, Kimball TR, Markham BE, and Molkentin JD. The transcription factors GATA4 and GATA6 regulate cardiomyocyte hypertrophy in vitro and in vivo. J Biol Chem 276: 30245-30253, 2001.
21. Lim HW, De Windt LJ, Steinberg L, Taigen T, Witt SA, Kimball TR, and Molkentin JD. Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy. Circulation 101: 2431-2437, 2000.
22. Mao Z and Wiedmann M. Calcineurin enhances MEF2 DNA binding activity in calcium-dependent survival of cerebellar granule neurons. J Biol Chem 274: 31102-31107, 1999.
23. McKee EE, Grier BL, Thompson GS, and McCourt JD. Isolation and incubation conditions to study heart mitochondrial protein synthesis. Am J Physiol Endocrinol Metab 258: E492-E502, 1990.
24. Meta L and Seitz C. Isolation of mitochondria with emphasis on heart mitochondria from small amounts of tissue. Methods Enzymol 55: 39-46, 1979.
25. Miller FJJ, Gutterman DD, Rios CD, Heistad DD, and Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res 82: 1298-1305, 1998.
26. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, and Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228, 1998.
27. Moore ML, Wang GL, Belaguli NS, Schwartz RJ, and McMillin JB. GATA-4 and serum response factor regulate transcription of the muscle-specific carnitine palmitoyltransferase I β in rat heart. J Biol Chem 276: 1026-1033, 2001.
28. Nijtmans LG, Henderson NS, Attardi G, and Holt IJ. Impaired ATP synthase assembly associated with a mutation in the human ATP synthase subunit 6 gene. J Biol Chem 276: 6755-6762, 2001.
29. Palmer JW, Tandler B, and Hoppel CL. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J Biol Chem 252: 8731-8739, 1977.
30. Rajamanickam C, Merten S, Kwiatkowska-Patzer B, Chuang CH, Zak R, and Rabinowitz M. Changes in mitochondrial DNA in cardiac hypertrophy in the rat. Circ Res 45: 505-515, 1979.
31. Rao A, Luo C, and Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 15: 707-747, 1997.
32. Schaeffer PJ, Vega R, Williams RS, and Kelly DP. Calcineurin signaling activates transcription of the PGC-1 gene: a potential mechanism for regulation of mitochondrial capacity. Circulation 104, Suppl: II-203, 2001.
33. Scholte HR, Yu Y, Ross JD, Oosterkamp II, Boonman AMC, and Busch HFM. Rapid isolation of muscle and heart mitochondria, the lability of oxidative phosphorylation and attempts to stabilize the process in vitro by taurine, carnitine and other compounds. Mol Cell Biochem 174: 61-66, 1997.
34. Sims JM, Patzer B, Kumudavalli-Reddy M, Martin AF, Rabinowitz M, and Zak R. The pathways of protein synthesis and degradation in normal heart and during development and regression of cardiac hypertrophy. Recent Adv Stud Card Struct Metab 12: 19-28, 1976.
35. Siwik DA, Tzortzis JD, Pimental DR, Chang DL, Pagano PJ, Singh K, Sawyer DB, and Colucci WS. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res 85: 147-153, 1999.
36. Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF, and Molkentin JD. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 281: 1690-1693, 1998.
37. Sussman MA, Welch S, Gude N, Khoury PR, Daniels SR, Kirkpatrick D, Walsh RA, Price RL, Lim HW, and Molkentin JD. Pathogenesis of dilated cardiomyopathy: molecular, structural, and population analyses in tropomodulin-overexpressing transgenic mice. Am J Pathol 155: 2101-2113, 1999.
38. Tan FL, Moravec CS, Li J, Apperson-Hansen C, McCarthy PM, Young JB, and Bond M. The gene expression fingerprint of human heart failure. Proc Natl Acad Sci USA 99: 11387-11392, 2002.
39. Tyler DD and Gonze J. The preparation of heart mitochondria from laboratory animals. Methods Enzymol 10: 75-101, 1967.
40. Vanden Hoek T, Becker LB, Shao ZH, Li CQ, and Schumacker PT. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res 86: 541-548, 2000.
41. Wallace DC. Mouse models for mitochondrial disease. Am J Med Genet 106: 71-93, 2001.
42. Wencker D, Chandra M, Armstrong RC, Garantziotis S, Factor SM, Shirani J, and Kitsis RN. Rescue of dilated cardiomyopathy by caspase inhibition in FKBP-caspase-8 transgenic mice. Circulation 102, Suppl: II-28, 2000.
43. Wu H, Rothermel B, Kanatous S, Rosenberg P, Naya FJ, Shelton JM, Hutcheson KA, DiMaio JM, Olson EN, Bassel-Duby R, and Williams RS. Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J 20: 6414-6423, 2001.
44. Xia Y, McMillin JB, Lewis A, Moore M, Zhu WG, Williams RS, and Kellems RE. Electrical stimulation of neonatal cardiac myocytes activates the NFAT3 and GATA4 pathways and upregulates the adenylosuccinate synthetase 1 gene. J Biol Chem 275: 1855-1863, 2000.
45. Zak R and Rabinowitz M. Molecular aspects of cardiac hypertrophy. Annu Rev Physiol 41: 539-552, 1979.
46. Zak R, Rabinowitz M, Rajamanickam C, Merten S, and Kwiatkowska-Patzer B. Mitochondrial proliferation in cardiac hypertrophy. Basic Res Cardiol 75: 171-178, 1980.